These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1898652)

  • 1. Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women.
    Van Erpecum KJ; Van Berge Henegouwen GP; Verschoor L; Stoelwinder B; Willekens FL
    Gastroenterology; 1991 Feb; 100(2):482-8. PubMed ID: 1898652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women.
    Uhler ML; Marks JW; Voigt BJ; Judd HL
    J Clin Endocrinol Metab; 1998 Feb; 83(2):410-4. PubMed ID: 9467549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic effects of transdermal estradiol.
    Chetkowski RJ; Meldrum DR; Steingold KA; Randle D; Lu JK; Eggena P; Hershman JM; Alkjaersig NK; Fletcher AP; Judd HL
    N Engl J Med; 1986 Jun; 314(25):1615-20. PubMed ID: 3012339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure.
    Steingold KA; Matt DW; DeZiegler D; Sealey JE; Fratkin M; Reznikov S
    J Clin Endocrinol Metab; 1991 Aug; 73(2):275-80. PubMed ID: 1906893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J; Zgliczynski S; Jeske W; Stopinska-Gluszak U; Srzednicki M; Brzezinska A; Zgliczynski W; Sadowski Z
    J Endocrinol Invest; 1992; 15(7):533-8. PubMed ID: 1280287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women.
    Vehkavaara S; Hakala-Ala-Pietilä T; Virkamäki A; Bergholm R; Ehnholm C; Hovatta O; Taskinen MR; Yki-Järvinen H
    Circulation; 2000 Nov; 102(22):2687-93. PubMed ID: 11094033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.
    Adami S; Rossini M; Zamberlan N; Bertoldo F; Dorizzi R; Lo Cascio V
    Maturitas; 1993 Nov; 17(3):191-6. PubMed ID: 8133793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
    De Lignieres B; Basdevant A; Thomas G; Thalabard JC; Mercier-Bodard C; Conard J; Guyene TT; Mairon N; Corvol P; Guy-Grand B
    J Clin Endocrinol Metab; 1986 Mar; 62(3):536-41. PubMed ID: 3080464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism.
    Ho KK; Weissberger AJ
    J Bone Miner Res; 1992 Jul; 7(7):821-7. PubMed ID: 1642149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study.
    Friend KE; Hartman ML; Pezzoli SS; Clasey JL; Thorner MO
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2250-6. PubMed ID: 8964860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal oestrogen for postmenopausal women: a double blind crossover comparative study with ethinyl oestradiol.
    Pattison NS; Uptin T; Knox B; France J
    Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):62-5. PubMed ID: 2562605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ; Ho KK
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrophin release, bone turnover and climacteric symptoms in postmenopausal women.
    Selby P; McGarrigle HH; Peacock M
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):241-9. PubMed ID: 2512035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
    Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a 17 beta estradiol gel preparation on hormone levels in menopausal women].
    Araya V; Contreras P; Aguirre C; Foradori A
    Rev Med Chil; 1995 Sep; 123(9):1116-21. PubMed ID: 8728735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
    Janssen YJ; Helmerhorst F; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.